SCHEMBL7116856

SCHEMBL7116856

COc1cccc(C(=O)[C@@H](Cc2ccc(F)c(F)c2)CN(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ MDM2 Q00987 1/20 0.43
▸ CES2 O00748 1/20 0.42
▸ CES1 P23141 1/20 0.42
▸ RAB9A P51151 5/20 0.41
▸ NPC1 O15118 4/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ POLB P06746 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ PARP1 P09874 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ ADORA2A P29274 1/20 0.40
▸ CHRNA1 P02708 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7116851 1.00 HTT (0.44) HTTKMT2AMEN1CYP2D6MDM2
Hydrochloric Acid SCHEMBL7164481 0.99 HTT (0.46) HTTKMT2AMEN1CYP2D6MDM2
Hydrochloric Acid SCHEMBL7164485 0.99 HTT (0.46) HTTKMT2AMEN1CYP2D6MDM2
SCHEMBL7125606 0.89 KMT2A (0.51) HTTKMT2AMEN1CYP2D6CES2
SCHEMBL7125610 0.89 KMT2A (0.51) HTTKMT2AMEN1CYP2D6CES2
SCHEMBL7115547 0.88 CYP2D6 (0.49) HTTKMT2AMEN1CYP2D6MDM2
SCHEMBL7115545 0.88 CYP2D6 (0.49) HTTKMT2AMEN1CYP2D6MDM2
SCHEMBL7121853 0.88 NPC1 (0.49) HTTKMT2AMEN1CYP2D6MDM2
Hydrochloric Acid SCHEMBL7161561 0.88 KMT2A (0.50) HTTKMT2AMEN1CYP2D6CES2
SCHEMBL7119780 0.88 NPC1 (0.49) HTTKMT2AMEN1CYP2D6MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6653508-B2 Use treating various medical conditions, including pain GRUENENTHAL GMBH (DE) 2003-11-25 — — US claimed
JP-2003505358-A — — 2003-02-12 — — JP claimed
US-20020161262-A1 3-Amino-2-benzyl-1-phenylpropane derivatives GRUENTENTHAL GMBH (DE) 2002-10-31 — — US claimed
EP-1196373-A1 3-AMINO-2-BENZYL-1-PHENYL-PROPANE DERIVATIVES Grünenthal GmbH (DE) 2002-04-17 — — EP claimed
WO-2001005743-A1 3-AMINO-2-BENZYL-1-PHENYL-PROPANE DERIVATIVES Grünenthal GmbH (DE) 2001-01-25 — — WO claimed
US-6653508-B2 Use treating various medical conditions, including pain GRUENENTHAL GMBH (DE) 2003-11-25 — — US disclosed
US-20020161262-A1 3-Amino-2-benzyl-1-phenylpropane derivatives GRUENTENTHAL GMBH (DE) 2002-10-31 — — US disclosed
EP-1196373-A1 3-AMINO-2-BENZYL-1-PHENYL-PROPANE DERIVATIVES Grünenthal GmbH (DE) 2002-04-17 — — EP disclosed
WO-2001005743-A1 3-AMINO-2-BENZYL-1-PHENYL-PROPANE DERIVATIVES Grünenthal GmbH (DE) 2001-01-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020161262-A1 3-Amino-2-benzyl-1-phenylpropane derivatives PYGL, CYP11B2, GOT2 HTT 626/4885KMT2A 3115/4885MEN1 3858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback